Liraglutide Improves Pancreatic Beta Cell Mass and Function in Alloxan-Induced Diabetic Mice
出版年份 2015 全文链接
标题
Liraglutide Improves Pancreatic Beta Cell Mass and Function in Alloxan-Induced Diabetic Mice
作者
关键词
Insulin, Blood sugar, Diabetes mellitus, Apoptosis, Oxidative stress, Insulin secretion, Hyperglycemia, Mouse models
出版物
PLoS One
Volume 10, Issue 5, Pages e0126003
出版商
Public Library of Science (PLoS)
发表日期
2015-05-05
DOI
10.1371/journal.pone.0126003
参考文献
相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。- Liraglutide and the Preservation of Pancreatic β-Cell Function in Early Type 2 Diabetes: The LIBRA Trial
- (2014) Ravi Retnakaran et al. DIABETES CARE
- Incretin Action in the Pancreas: Potential Promise, Possible Perils, and Pathological Pitfalls
- (2013) D. J. Drucker DIABETES
- Inactivation of specific β cell transcription factors in type 2 diabetes
- (2013) Shuangli Guo et al. JOURNAL OF CLINICAL INVESTIGATION
- The role of FOXO1 in β-cell failure and type 2 diabetes mellitus
- (2013) Tadahiro Kitamura Nature Reviews Endocrinology
- The molecular mechanisms of pancreatic β-cell glucotoxicity: Recent findings and future research directions
- (2012) Mohammed Bensellam et al. MOLECULAR AND CELLULAR ENDOCRINOLOGY
- Pancreatic β-cells are generated by neogenesis from non-β-cells after birth
- (2011) Korefumi Nakamura et al. BIOMEDICAL RESEARCH-TOKYO
- The human glucagon-like peptide-1 analogue liraglutide preserves pancreatic beta cells via regulation of cell kinetics and suppression of oxidative and endoplasmic reticulum stress in a mouse model of diabetes
- (2011) M. Shimoda et al. DIABETOLOGIA
- Two incretin hormones GLP-1 and GIP: Comparison of their actions in insulin secretion and β cell preservation
- (2011) Daisuke Yabe et al. PROGRESS IN BIOPHYSICS & MOLECULAR BIOLOGY
- Exendin-4 Suppresses Src Activation and Reactive Oxygen Species Production in Diabetic Goto-Kakizaki Rat Islets in an Epac-Dependent Manner
- (2010) E. Mukai et al. DIABETES
- -Cell Growth and Regeneration: Replication Is Only Part of the Story
- (2010) S. Bonner-Weir et al. DIABETES
- A novel dipeptidyl peptidase IV inhibitor DA-1229 ameliorates streptozotocin-induced diabetes by increasing β-cell replication and neogenesis
- (2010) Jae Min Cho et al. DIABETES RESEARCH AND CLINICAL PRACTICE
- Exenatide and liraglutide: different approaches to develop GLP-1 receptor agonists (incretin mimetics) – preclinical and clinical results
- (2009) Sten Madsbad BEST PRACTICE & RESEARCH CLINICAL ENDOCRINOLOGY & METABOLISM
- One-Year Treatment With Exenatide Improves -Cell Function, Compared With Insulin Glargine, in Metformin-Treated Type 2 Diabetic Patients: A randomized, controlled trial
- (2009) M. C. Bunck et al. DIABETES CARE
- The safety and efficacy of liraglutide with or without oral antidiabetic drug therapy in type 2 diabetes: an overview of the LEAD 1-5 studies
- (2009) L. Blonde et al. DIABETES OBESITY & METABOLISM
- Exendin-4 Potentiates Insulinotropic Action Partly via Increasing β-Cell Proliferation and Neogenesis and Decreasing Apoptosis in Association With the Attenuation of Endoplasmic Reticulum Stress in Islets of Diabetic Rats
- (2009) Dae Young Kwon et al. JOURNAL OF PHARMACOLOGICAL SCIENCES
- Liraglutide, a once-daily human GLP-1 analogue, improves pancreatic B-cell function and arginine-stimulated insulin secretion during hyperglycaemia in patients with Type 2 diabetes mellitus
- (2008) T. Vilsbøll et al. DIABETIC MEDICINE
- Weighing up β-cell mass in mice and humans: Self-renewal, progenitors or stem cells?
- (2008) Neil A. Hanley et al. MOLECULAR AND CELLULAR ENDOCRINOLOGY
Add your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload NowCreate your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create Now